The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
PharmaTox Master's student: Kristiane Fosskaug
June 13, 2017 1:54 PM
Master's student Kristiane Fosskaug defended her thesis on June 1st with the title “Kan prenatal paracetamoleksponering påvirke nevroutviklingen? In Vivo og in vitro studier i kyllingembryo og PC12-celler for vurdering av effekter på genetiske regulatorer, nevronale utviklingsmarkører og lillehjernens morfologi".
PharmaTox Master's student: Maria Øygarden
May 12, 2017 11:11 AM
Master's student Maria Øygarden defended her thesis on April 20th with the title “Studier av antidepressiva i kyllinglillehjerne og PC12-celler – Effekter av escitalopram og venlafaksin på genetiske regulatorer og neuronale utviklingsmarkører”.
Oslo Epigenetics Mini Symposium 9th of May 2017
Apr. 11, 2017 9:38 AM
The symposium is organised by Ragnhild Eskeland on behalf of the Norwegian Center for Stem Cell Research and Department of Biosciences, UiO.
Lecture by Prof. Tobias Kurth
Mar. 30, 2017 11:28 AM
On May 3rd, Prof. Tobias Kurth will give an exciting lecture: "What if the results between propensity score and standard methods differ?"
PharmaTox PhD and postdoc seminar
Mar. 30, 2017 11:15 AM
PharmaTox arranged a seminar March 24th.